N/A Completed N=5,012 Randomized Single-blind Health Services Research

Timely Nudge About Lab Results to Increase myGeisinger Uptake

Telehealth · Health Behavior

Source: ClinicalTrials.gov NCT04333199 ↗

Enrolled (actual)

5,012

Serious AEs

—

Results posted

May 2021

Primary outcomePrimary: Enrollment - Timely Email (Combined Email Arms) vs. no Intervention — 65; 361 Participants — p=<0.001

Summary

The purpose of the current study is to test whether sending email communications in a timely manner - when patients have laboratory results available to view on the myGeisinger patient portal - increases enrollment in the portal.

Outcome Measures

Outcome	Result	p-value
PRIMARY Enrollment - Timely Email (Combined Email Arms) vs. no Intervention	141; 488	<0.001 sig
SECONDARY Enrollment - Email Including a "Get Started" Button vs. a "View Results" Button	190; 159	0.154
SECONDARY Email Opened - Email Including a "Get Started" Button vs. a "View Results" Button	654; 617	0.571
SECONDARY Link Clicked - Email Including a "Get Started" Button vs. a "View Results" Button	494; 307	<0.001 sig
SECONDARY Unsubscribed - Email Including a "Get Started" Button vs. a "View Results" Button	2; 2	—
SECONDARY Enrollment - Timely Email (Combined Email Arms) vs. no Intervention	141; 488	<0.001 sig

Eligibility Criteria

Inclusion Criteria

Geisinger patient for whom a lab was ordered within 30 days prior to email date
Patient's lab test result released day before email date

Exclusion Criteria

Patient already enrolled in myGeisinger
Patient has already declined myGeisinger

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04333199). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.